Table 3 Univariate and multivariate hazard ratios of the risk of treatment modification in the group of patients over 50 years old

Gender

 Male

0.14

0.61

0.31

1.81

0.37

0.71

0.33

1.51

 Female

–

1.00

–

–

–

1.00

–

–

HIV risk group

 MSM

0.08

0.62

0.36

1.06

0.09

0.60

0.33

1.09

 Heterosexual

–

1.00

–

–

–

1.00

–

–

 IDU

0.33

1.41

0.70

2.84

0.58

1.29

0.52

3.21

 Other

0.44

0.70

0.28

1.74

0.50

0.72

0.28

1.85

 Unknown

0.37

0.72

0.35

1.48

0.52

0.78

0.37

1.66

Nadir CD4 value

 Per 100 increase

0.62

1.05

0.87

1.25

0.18

0.84

0.66

1.08

Age in years

 Per 1 year increase

0.87

1.00

0.97

1.04

0.73

1.01

0.97

1.05

Anti-HCV Ab

 Positive

0.22

1.43

0.80

2.54

0.33

0.65

0.28

1.53

 Negative

–

1.00

–

–

–

1.00

–

–

 Unknown

0.55

0.77

0.33

1.81

0.29

0.60

0.23

1.56

Anti-HBc Ab

 Positive

0.50

1.2

0.7

2.06

0.30

1.36

0.76

2.45

 Negative

–

1.00

–

–

–

1.00

–

–

 Unknown

0.29

1.37

0.76

2.46

0.36

1.37

0.70

2.71

Baseline hemoglobin

 Per 1 g/dL increase

0.05

1.02

1.0

1.04

0.14

1.01

0.995

1.04

ARV group

 PI

0.03

1.79

1.06

3.02

0.01

2.17

1.18

3.98

 NNRTI

–

1.00

–

–

–

1.00

–

–

 ITI

0.99

0

0

0

0.99

0

0

–

 FI

0.99

0

0

0

0.99

0

0

–

Late presentation

 Yes

0.03

0.61

0.39

0.96

0.02

0.45

0.23

0.90